. .
Clinical Stem 1
Non-smoking female with a new right upper lobe lung mass and three PET-positive mediastinal lymph nodes
Learning Outcome


At the conclusion of the 1st Clinical Stem webcast, viewers will be able to:
  1. Describe mediastinal staging and EBUS-guided nodal-sampling strategies.
  2. Describe the rationale for downstream molecular analysis of small tissue specimens.
  3. Describe ways to assure specimen adequacy for diagnosis and molecular testing.
  4. Describe indications for repeat biopsy and molecular analysis in case of disease progression.
  5. Describe how molecular analysis of adequate specimens helps determine prognosis and potential response or resistance to therapy.
Narrative Companion to Clinical Stem 1
Each fictitious clinical case scenario is based on a conglomerate of real patient data. Cases have been modified to avoid any possibility for patient identification and to help meet educational objectives. Any resemblance to real persons, living or deceased, is purely coincidental.

The content for these webcasts has been developed by members of the World Association for Bronchology and Interventional Pulmonology. All content was reviewed by an independent multidisciplinary team of experts. Unless otherwise specified, all content is the property of WABIP.
A collaborative project with Pfizer Oncology